Corrigendum to “Double-blinded prospective randomized clinical trial in knee joint osteoarthritis treatment: safety assessment and performance of trehalose hyaluronic acid versus standard infiltrative therapy based on medium-weight sodium hyaluronate” [Journal of Cartilage & Joint Preservation 2 (2022) 100043](S2667254522000063)(10.1016/j.jcjp.2022.100043)

The authors regret that a sentence was incorrect in the published article. In the Methods section under the Outcomes heading, the first sentence of the second paragraph should be replaced by “NT-HA is composed of medium molecular weight sodium hyaluronate (1200–1500 kDa). T-HA is composed of 80% medium-weight sodium hyaluronate (1200–1500 kDa) and 20% low-weight hyaluronic acid (200–400 kDa) plus the addition of 1% trehalose.” The authors would like to apologize for any inconvenience caused. DOI of original article: https://doi.org/10.1016/j.jcjp.2022.100043